PO-0996: Early mortality in stage III NSCLC after radical non-surgical therapy following ESMO guidelines. (November 2020) - Ronden-Kianoush, M.; de Vries, I.F. Remmerts; Bahce, I.; De Haan, P.F.; Tiemessen, M.A.; Spoelstra, F.O.B.; Van Diepen, V.D.M.; Haasbeek, C.J.A.; Tarasevych, S.; Daniels, H.J.M.A.; Dahele, M.R.; Hashemi, S.M.; et al.